First Time Loading...

Aslan Pharmaceuticals Ltd
NASDAQ:ASLN

Watchlist Manager
Aslan Pharmaceuticals Ltd Logo
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Watchlist
Price: 0.424375 USD -0.01% Market Closed
Updated: May 7, 2024

Aslan Pharmaceuticals Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aslan Pharmaceuticals Ltd
Net Income (Common) Peer Comparison

Comparables:

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Net Income (Common)
-$11.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Aslan Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
-11.6m USD

Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Net Income (Common) amounts to -11.6m USD.

What is Aslan Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
15%

Over the last year, the Net Income (Common) growth was 59%. The average annual Net Income (Common) growth rates for Aslan Pharmaceuticals Ltd have been 26% over the past three years , 15% over the past five years .